ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.

J Exp Clin Cancer Res · 2018 · PMC6019204 · PMID 29940998

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The high expression of amphiregulin, a specific ligand of the EGFR, shows a highly significant correlation with cisplatin resistance in a variety of human breast cancer cell lines [ 35 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.